A nurse is preparing to assess a client brought to the emergency department by a concerned spouse, who reports the client has been "extremely depressed lately." Which is the priority assessment?

Choice A reason: Providing a safe environment is a foundational nursing intervention for clients with anxiety disorders. Anxiety is mediated by hyperactivation of the amygdala and the sympathoadrenal axis, and environmental stressors such as excessive noise, bright lighting, crowding, or unpredictability can significantly exacerbate physiological and psychological arousal. A calm, quiet, and predictable environment reduces sensory stimulation and promotes parasympathetic nervous system activation, facilitating the de-escalation of acute anxiety. Ensuring environmental safety also addresses the client's subjective sense of security, which is foundational to anxiety management and therapeutic engagement.

Choice B reason: Instructing and assisting the client to focus on deep breathing is a well-established evidence-based intervention for the management of anxiety. Diaphragmatic breathing activates the parasympathetic nervous system by stimulating the vagus nerve, reducing heart rate and blood pressure, and counteracting the physiological arousal of the sympathetic stress response. Controlled breathing techniques, such as the 4-7-8 technique or square breathing, have demonstrated efficacy in reducing anxiety severity in both acute and chronic presentations. This intervention is non-pharmacological, empowering, and easily practiced independently, making it appropriate for client teaching and immediate implementation.

Choice C reason: Leaving the client alone during a panic attack is a contraindicated and non-therapeutic nursing intervention. The presence of the nurse provides an external regulating influence that helps reduce the client's sense of terror and impending doom during acute autonomic hyperactivation. Abandonment during a panic attack deprives the client of crucial reassurance, safety communication, and guidance through coping techniques such as breathing and grounding. It also violates the standard of care for psychiatric nursing, which mandates therapeutic presence and continuous safety monitoring during episodes of acute psychological distress. This choice is therefore not appropriate and is correctly excluded from the answer.

Choice D reason: Engaging the client in a collaborative exploration of strategies to decrease stressors is a therapeutic and educationally appropriate nursing intervention for anxiety disorders. Identifying and addressing modifiable stressors is a core component of cognitive-behavioral therapy (CBT) and psychoeducational approaches to anxiety management. This intervention promotes client insight, develops problem-solving skills, and empowers the client to take an active role in managing their anxiety triggers. It addresses the environmental and psychosocial contributors to anxiety rather than only the acute symptomatology, contributing to long-term self-management and relapse prevention.

Choice E reason: Teaching relaxation techniques — including progressive muscle relaxation (PMR), guided imagery, mindfulness-based stress reduction (MBSR), and biofeedback — is an evidence-based nursing intervention for anxiety disorders. These techniques engage the parasympathetic nervous system, reduce cortisol secretion, lower muscular tension, and interrupt the cycle of cognitive and somatic anxiety escalation. Teaching relaxation skills builds the client's repertoire of self-regulatory strategies, promotes self-efficacy, and reduces dependence on pharmacological interventions. This approach is consistent with integrative psychiatric-mental health nursing care guidelines and is appropriate for implementation across care settings.

Choice A reason: Benzodiazepines are the pharmacological standard of care for the management of acute alcohol withdrawal syndrome (AWS). Alcohol exerts its central nervous system depressant effects primarily through potentiation of gamma-aminobutyric acid (GABA) at the GABA-A receptor and inhibition of N-methyl-D-aspartate (NMDA) glutamate receptors. Chronic alcohol exposure leads to compensatory downregulation of GABA-A receptors and upregulation of NMDA receptors. Upon abrupt cessation of alcohol, this imbalance results in central nervous system hyperexcitability, manifesting as tremor, diaphoresis, tachycardia, hypertension, anxiety, seizures, and potentially life-threatening delirium tremens. Benzodiazepines, such as diazepam, lorazepam, and chlordiazepoxide, restore GABAergic inhibitory tone, suppress excitatory hyperactivity, prevent seizures, and reduce mortality from alcohol withdrawal.

Choice B reason: Mood stabilizers such as lithium carbonate, valproate, and carbamazepine are not the primary class of medications used for the management of acute alcohol withdrawal. While valproate and carbamazepine have some evidence as adjunctive agents in alcohol detoxification, they do not address the acute GABAergic deficiency and glutamatergic hyperactivity that underlie the pathophysiology of AWS as effectively or as rapidly as benzodiazepines. Lithium has no established role in alcohol withdrawal management. Mood stabilizers are used in the treatment of bipolar disorder and do not constitute the standard of safe withdrawal management for alcohol use disorder.

Choice C reason: Antidepressants, including selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs), address dysregulation of monoamine neurotransmitter systems and are indicated for the treatment of major depressive disorder and related conditions. They do not act on GABA-A receptors or NMDA glutamate receptors, which are the primary pharmacological targets in alcohol withdrawal management. Antidepressants have no established efficacy in preventing alcohol withdrawal seizures or delirium tremens and are not part of standard detoxification protocols for acute alcohol withdrawal syndrome.

Choice D reason: Antipsychotic medications, such as haloperidol, chlorpromazine, and atypical agents including quetiapine and olanzapine, primarily exert their effects through blockade of dopamine D2 receptors and, in the case of atypicals, serotonin 5-HT2A receptors. They do not address the GABAergic and glutamatergic imbalance central to alcohol withdrawal pathophysiology and have not been shown to reliably prevent alcohol withdrawal seizures. Furthermore, typical antipsychotics lower the seizure threshold, which is particularly dangerous in the context of alcohol withdrawal, where seizure risk is already elevated. Antipsychotics are therefore not the first-line or standard medication class for safe alcohol withdrawal management.